Literature DB >> 14718526

Human disease-related mutations in cytochrome b studied in yeast.

Nicholas Fisher1, C Kate Castleden, Ingrid Bourges, Gael Brasseur, Genevieve Dujardin, Brigitte Meunier.   

Abstract

Several mutations in the mitochondrially encoded cytochrome b have been reported in patients. To characterize their effect, we introduced six "human" mutations, namely G33S, S152P, G252D, Y279C, G291D, and Delta252-259 in the highly similar yeast cytochrome b. G252D showed wild type behavior in standard conditions. However, Asp-252 may interfere with structural lipid and, in consequence, destabilize the enzyme assembly, which could explain the pathogenicity of the mutation. The mutations G33S, S152P, G291D, and Delta252-259 were clearly pathogenic. They caused a severe decrease of the respiratory function and altered the assembly of the iron-sulfur protein in the bc(1) complex, as observed by immunodetection. Suppressor mutations that partially restored the respiratory function impaired by S152P or G291D were found in or close to the hinge region of the iron-sulfur protein, suggesting that this region may play a role in the stable binding of the subunit to the bc(1) complex. Y279C caused a significant decrease of the bc(1) function and perturbed the quinol binding. The EPR spectra showed an altered signal, indicative of a lower occupancy of the Q(o) site. The effect of human mutation of residue 279 was confirmed by another change, Y279A, which had a more severe effect on Q(o) site properties. Thus by using yeast as a model system, we identified the molecular basis of the respiratory defect caused by the disease mutations in cytochrome b.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718526     DOI: 10.1074/jbc.M313866200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Molecular mechanisms of superoxide production by complex III: a bacterial versus human mitochondrial comparative case study.

Authors:  Pascal Lanciano; Bahia Khalfaoui-Hassani; Nur Selamoglu; Anna Ghelli; Michela Rugolo; Fevzi Daldal
Journal:  Biochim Biophys Acta       Date:  2013-03-28

2.  Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.

Authors:  Edinson Lucumi; Claire Darling; Hyunil Jo; Andrew D Napper; Rajesh Chandramohanadas; Nicholas Fisher; Alison E Shone; Huiyan Jing; Stephen A Ward; Giancarlo A Biagini; William F DeGrado; Scott L Diamond; Doron C Greenbaum
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

3.  Analysis of COX2 mutants reveals cytochrome oxidase subassemblies in yeast.

Authors:  Susannah Horan; Ingrid Bourges; Jan-Willem Taanman; Brigitte Meunier
Journal:  Biochem J       Date:  2005-09-15       Impact factor: 3.857

4.  Loss of a conserved tyrosine residue of cytochrome b induces reactive oxygen species production by cytochrome bc1.

Authors:  Dong-Woo Lee; Nur Selamoglu; Pascal Lanciano; Jason W Cooley; Isaac Forquer; David M Kramer; Fevzi Daldal
Journal:  J Biol Chem       Date:  2011-03-23       Impact factor: 5.157

5.  HDQ, a potent inhibitor of Plasmodium falciparum proliferation, binds to the quinone reduction site of the cytochrome bc1 complex.

Authors:  Cindy Vallières; Nicholas Fisher; Thomas Antoine; Mohammed Al-Helal; Paul Stocks; Neil G Berry; Alexandre S Lawrenson; Stephen A Ward; Paul M O'Neill; Giancarlo A Biagini; Brigitte Meunier
Journal:  Antimicrob Agents Chemother       Date:  2012-04-30       Impact factor: 5.191

6.  Catalytic Reactions and Energy Conservation in the Cytochrome bc1 and b6f Complexes of Energy-Transducing Membranes.

Authors:  Marcin Sarewicz; Sebastian Pintscher; Rafał Pietras; Arkadiusz Borek; Łukasz Bujnowicz; Guy Hanke; William A Cramer; Giovanni Finazzi; Artur Osyczka
Journal:  Chem Rev       Date:  2021-01-19       Impact factor: 60.622

7.  Combining Inhibitor Resistance-conferring Mutations in Cytochrome b Creates Conditional Synthetic Lethality in Saccharomyces cerevisiae.

Authors:  Martina G Ding; Jean-Paul di Rago; Bernard L Trumpower
Journal:  J Biol Chem       Date:  2009-01-29       Impact factor: 5.157

8.  Saccharomyces cerevisiae-based mutational analysis of the bc1 complex Qo site residue 279 to study the trade-off between atovaquone resistance and function.

Authors:  Zehua Song; Jérôme Clain; Bogdan I Iorga; Zhou Yi; Nicholas Fisher; Brigitte Meunier
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

9.  Substrate redox potential controls superoxide production kinetics in the cytochrome bc complex.

Authors:  Jonathan L Cape; Divesh Aidasani; David M Kramer; Michael K Bowman
Journal:  Biochemistry       Date:  2009-11-17       Impact factor: 3.162

10.  Role of the -PEWY-glutamate in catalysis at the Q(o)-site of the Cyt bc(1) complex.

Authors:  Doreen Victoria; Rodney Burton; Antony R Crofts
Journal:  Biochim Biophys Acta       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.